loader2
Partner With Us NRI

Hester Biosciences Ltd share Price Today

Company details

2,466.95
2,587.35
1,292.85
3,379.00
6M Return 77.84%
1Y Return 49.22%
Mkt Cap.(Cr) 2,114.93
Volume 4,485
Div Yield 0.24%
OI
-
OI Chg %
-
Volume 4,485
NSE

Invest in Market with Confidence: High performance strike rate of over 72%

Trade, sell, withdraw – all in minutes!
icon 27 Years

of legacy

icon 4.4 Star

App Rating

icon 1 Crore +

Customers

Open a Trading Account

Achieve your Investment goals today!

+91
Please enter valid Mobile Number
Get Started

Pharmaceuticals company Hester Biosciences announced Q1FY25 results:

  • Q1FY25 Standalone Divisional Product sales up by 37% & Profit up by 30%
  • Q1FY25 Consolidated Divisional Product sales up by 35% & Profit up by 9%
  • The divisional performance has demonstrated growth in the current quarter compared to Q1FY24, with sales increasing by 37%.
  • The overall sales show a decrease of 9% QoQ, primarily attributed to the one-time sales of other pharmaceutical products in Q1FY24.
  • Hester focused on higher-margin products and solutions in Q1FY25, leading to a significant rise in gross profit margin from 57% to 69%.
  • Increased revenue from divisional product sales allowed for better absorption of fixed costs, resulting in a 5% improvement in EBITDA%.
  • Overall absolute PAT increased by 30% and PAT% ratio increased by 3%, reflecting improved operational efficiency.

Result PDF

View Other Company Results

Hester Biosciences Ltd shares SWOT Analysis

Strengths (8)

  • Rising Net Cash Flow and Cash from Operating activity
  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Increasing Revenue every quarter for the past 2 quarters

Weakness (6)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years

Opportunity (0)

Data not found

Threats (1)

  • High PE (PE > 40)
Discover More

Resistance and support

R1 2,560.0
R2 2,633.9
R3 2,680.4
Pivot

2,513.47

S1 2,439.6
S2 2,393.1
S3 2,319.2
EMA SMA
2,474.9
2,470.0
2,328.8
2,104.1
2,447.2
2,578.2
2,344.7
1,918.4
Delivery and volume
Discover More
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
RAJIV DINESH GANDHI Bulk Purchase 2017-03-22 732.1 90000 BSE
HESTER COATINGS PRIVATE LIMITED Bulk Sell 2017-03-22 732.1 90000 BSE
RAJIV DINESH GANDHI Block Purchase 2017-03-22 732.1 90000 BSE
Discover More
Name Category Shares
Rajiv Dinesh Gandhi PROMOTER 10.47%
Sanjiv Dinesh Gandhi PROMOTER 8.2%
Nina Rajiv Gandhi PROMOTER 8.19%
Shaila Bhupendra Gandhi PROMOTER 5.78%
Bhupendra Vithaldas Gandhi PROMOTER 4.69%
Anup Chandravadan Kapadia PROMOTER 2.68%
Biolink Healthcare Limited PROMOTER 2.93%
Hester Coatings LLP PROMOTER 0.75%
Ravin Gandhi PROMOTER 4.74%
Bela Gandhi PROMOTER 4.71%

FINANCIALS

Sales
Operating Profit
Profit after Tax
DISCOVER MORE
Equity
Reserves and Surplus
Debt
DISCOVER MORE
Sales
Operating Profit
Profit after Tax
DISCOVER MORE
PE
Debt/Equity
P BV
DISCOVER MORE

Hester Biosciences Ltd Stocks COMPARISON

Financials( ₹ in Cr) Hester Biosciences Ltd Sun Pharmaceuticals Industries Ltd Divis Laboratories Ltd Cipla Ltd Torrent Pharmaceuticals Ltd
Price 2,486.10 1,948.70 5,457.90 1,672.50 3,482.60
% Change 1.35 4.31 1.53 2.13 0.34
Mcap ₹ Cr 2,114.93 4,67,558.41 1,44,890.33 1,35,057.39 1,17,866.86
Revenue TTM ₹ Cr 304.55 48,496.85 7,845.00 25,774.09 10,727.84
Net Profit TTM ₹ Cr 21.17 9,648.44 1,600.00 4,155.31 1,656.38
PE TTM 109.25 44.34 86.44 30.37 70.40
1 Year Return 49.22 73.36 46.38 41.82 88.54
ROCE 8.74 17.20 16.41 22.27 23.21
ROE 7.41 16.13 12.15 16.58 25.38
DISCOVER MORE
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 291.80 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 17,492.71 71,886.12
LAST 3M 78,204.11 61,813.64
LAST 6M 1,87,352.46 86,996.15
LAST 12M 3,32,953.72 1,53,700.57

Hester Biosciences Ltd Information

Stock PE (TTM)
109.25
Promoter Holding
53.73%
Book Value
343.0087
ROCE
8.74%
ROE
7.41%
Description

  • Incorporated as a private limited company in Apr.`87, Hester Pharmaceutical (HPL) was converted into a public limited company in Nov.`93. HPL markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium. The company`s own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation. During 1996-97, company successfully implemented veterinary vaccine and commercial production has begun. The company has received licenses for producing 10 additional poultry vaccines.It has also signed an manufacturing agreement with Sinsui Inc for producing poultry vaccines.

Read More

No Data Found

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524669
NSE Code : HESTERBIO
Book Closure Date (Month) : Sep
BSE Group : B
ISIN : INE782E01017

FAQ’s on Hester Biosciences Ltd Shares

You can buy Hester Biosciences Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Hester Biosciences Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Sep 27, 2024 03:56 PM the closing price of Hester Biosciences Ltd was Rs.2,486.10.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Sep 27, 2024 03:56 PM, the market cap of Hester Biosciences Ltd stood at Rs. 2,114.93 Cr.

The latest PE ratio of Hester Biosciences Ltd as of Sep 27, 2024 03:56 PM is 109.25

The latest PB ratio of Hester Biosciences Ltd as of Sep 27, 2024 03:56 PM is 0.14

The 52-week high of Hester Biosciences Ltd share price is Rs. 3,379.00 while the 52-week low is Rs. 1,292.85

According to analyst recommendations, Hester Biosciences Ltd Share has a "" rating for the long term.

Download App

Download Our App

Play Store App Store
market app

Open a Trading Account

Achieve your Investment goals today!

+91
Please enter valid Mobile Number
Get Started
Open a Trading Account